Etiology of OHSS and use of dopamine agonists

被引：72

作者：

Soares, Sergio Reis ^{[1
]}

机构：

[1] IVI Lisboa, Inst Valenciano Infertilidad, Lisbon, Portugal

来源：

FERTILITY AND STERILITY | 2012年 / 97卷 / 03期

关键词：

OHSS; VEGF; dopamine agonists; vascular permeability; ovarian stimulation; ENDOTHELIAL GROWTH-FACTOR; OVARIAN HYPERSTIMULATION SYNDROME; VASCULAR-PERMEABILITY FACTOR; HUMAN GRANULOSA-CELLS; FACTOR VEGF; BROMOCRIPTINE TREATMENT; INHIBITS ANGIOGENESIS; LUTEAL ANGIOGENESIS; SIGNAL-TRANSDUCTION; HEART-DISEASE;

D O I：

10.1016/j.fertnstert.2011.12.046

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

Vascular endothelial growth factor is the factor that causes increased capillary permeability and therefore the most serious manifestations of ovarian hyperstimulation syndrome. Dopamine agonists can both prevent and treat ovarian hyperstimulation syndrome by blocking expression of the vascular endothelial growth factor receptor. (Fertil Steril (R) 2012; 97:517-22. (C) 2012 by American Society for Reproductive Medicine.)

引用

页码：517 / 522

页数：6

共 74 条

[1]

Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome [J].

Abramov, Y ;

Barak, V ;

Nisman, B ;

Schenker, JG .

FERTILITY AND STERILITY, 1997, 67 (02) :261-265

[2]

Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome [J].

Agrawal, R ;

Tan, SL ;

Wild, S ;

Sladkevicius, P ;

Engmann, L ;

Payne, N ;

Bekir, J ;

Campbell, S ;

Conway, G ;

Jacobs, H .

FERTILITY AND STERILITY, 1999, 71 (02) :287-293

[3]

The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome [J].

Albert, C ;

Garrido, N ;

Mercader, A ;

Rao, CV ;

Remohí, J ;

Simón, C ;

Pellicer, A .

MOLECULAR HUMAN REPRODUCTION, 2002, 8 (05) :409-418

[4]

Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment:: a pilot study [J].

Alvarez, Claudio ;

Alonso-Muriel, Isabel ;

Garcia, Gabriela ;

Crespo, Juana ;

Bellver, Jose ;

Simon, Carlos ;

Pellicer, Antonio .

HUMAN REPRODUCTION, 2007, 22 (12) :3210-3214

[5]

Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction [J].

Alvarez, Claudio ;

Marti-Bonmati, Luis ;

Novella-Maestre, Edurne ;

Sanz, Roberto ;

Gomez, Raul ;

Fernandez-Sanchez, Manuel ;

Simon, Carlos ;

Pellicer, Antonio .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :2931-2937

[6]

Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease [J].

Antonini, Angelo ;

Poewe, Werner .

LANCET NEUROLOGY, 2007, 6 (09) :826-829

[7]

High dose cabergoline in management of ovarian hyperstimulation syndrome [J].

Ata, Baris ;

Seyhan, Ayse ;

Orhaner, Serbulent ;

Urman, Bulent .

FERTILITY AND STERILITY, 2009, 92 (03) :1168.e1-1168.e4

[8]

Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis [J].

Basu, S ;

Sarkar, C ;

Chakroborty, D ;

Nagy, J ;

Mitra, RB ;

Dasgupta, PS ;

Mukhopadhyay, D .

CANCER RESEARCH, 2004, 64 (16) :5551-5555

[9]

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor [J].

Basu, S ;

Nagy, JA ;

Pal, S ;

Vasile, E ;

Eckelhoefer, IA ;

Bliss, VS ;

Manseau, EJ ;

Dasgupta, PS ;

Dvorak, HF ;

Mukhopadhyay, D .

NATURE MEDICINE, 2001, 7 (05) :569-574

[10]

Alteration of dopamine D-2 receptors in human malignant stomach tissue [J].

Basu, S ;

Dasgupta, PS .

DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (06) :1260-1264

← 1 2 3 4 5 6 7 8 →